HGSOC patients with BRCA1/2 mutations had significantly higher peritoneal tumour load and significantly increased frequency of bulky lymph nodes at diagnosis than those with wild-type BRCA genes [36]. The gene discussed is BRCA1; the disease is neoplasm.